A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce seizures in patients with tuberous sclerosis complex (TSC) -- a genetic disease characterized by benign tumors on multiple organ systems. TSC is estimated to affect more than a million individuals throughout the world.

Source: Drug shows dramatic reduction in seizures in patients with tuberous sclerosis complex


David Cottle

UBB Owner & Administrator